Carestart Covid-19 Antigen Test Rchm-02071
New Products From This Supplier
CARESTART COVID-19 ANTIGEN TEST RCHM-02071
The CareStart™ COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens directly collected, or collected in BD universal transport media, from individuals suspected of COVID-19 by their healthcare provider within five days of symptom onset. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
Business Nature
Wholesaler
Country/Region
Jakarta, Indonesia
Main Products
Medical Devices, Medical Devices...
We are reliable Suppliers of All kinds of products from United States we get the best prices for all our clients. We assist in shipping to all major seaports or airport.
